Biotech Stock Review

Citius Pharma (CTXR) Flexes Muscle in Business Update. Remains Our Top Idea.

Added to Watch List November 2019 @$0.55. Named Our Top Idea in 2020 @$1.02.Remains Our Top Idea in 2021...

Citius Pharma (CTXR) $2.15. Price Target of $8.00 Maintained, Post Safety and Efficacy Review.

Investment Banker Buy Rating Maintained: DSMB Gives the Thumbs Up – Data in Early 2022. CITIUS NEWS ARCHIVE

Aphex BioCleanse (SNST) Making Serious Headlines.

Relatively quiet for most of the year. Aphex BioCleanse, our favorite Super Bug sanitizer company, made two back-to-back announcements - signaling things...
Issam Radd

Citius (CTXR): Halt For Superiority On The Horizon? (SeekingAlpha).

Jun. 15, 2021 10:41 AM ET Citius Pharmaceuticals, Inc. (CTXR) Summary
Biotech Stock Review. Citius, CTXR

More Great News From Citius Pharma (CTXR).

UPDATED CHART 6-15-21 Mino-Lok® Phase III, FDA NewsRussell 2000 Index NewsTechnical Breakout News
Auris Medical, Altamira Therapeutics

Adding Auris Medical (EARS) $3.50 to Biotech Watch List.

Auris Medical soared 590% in one Week on Covid Related News on December 1st, 2020. LIFT OFF...
Aphex Biocleanse Systems

Aphex BioCleanse Further Expands Distribution Channels.

Aphex BioCleanse Systems Announces Partnership With Bifulco Consulting Group to Expand Distribution Channels PITTSFORD, N.Y., May 20, 2021...

Citius Pharma (CTXR) Updates Shareholders.

Citius Update Stem Cell Study Citius Pharmaceuticals, Inc announced that it will present a poster at the International Society...
Dermaphex

Aphex BioCleanse System’s (SNST) Significant Hand Sanitizer Purchase Order.

Aphex BioCleanse Systems Announces Significant Purchase Order for Proprietary, Alcohol-Free Hand Sanitizer Product PITTSFORD, N.Y. , May 4, 2021 /PRNewswire/ -- Aphex...

Stem Cell Play Organicell (BPSR) Screams Higher.

Stock Levitates After Series of Positive Press Releases on Zofrin. Added to the Watch List in April a...

Latest article

Nine Page Summary Report on GeoVax (GOVX)

This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...